The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S. that will no longer be administered under an emergency use authorization.

The FDA action comes weeks after US Health Secretary Robert F. Kennedy Jr said the government would no longer recommend the COVID vaccine for healthy children or pregnant people.

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

With the pandemic cutting an ever-broadening swath through the country, Moderna’s announcement that preliminary data indicate its COVID-19 vaccine was 95% effective offered Americans a much ...

Moderna Inc. said its COVID-19 vaccine remained 93% effective six months after the second shot as it reported second-quarter earnings and revenue that beat expectations.

In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 participants ...

Moderna’s Covid Vaccine: What You Need to Know. By Carl Zimmer and Denise Grady. Published Nov. 16, 2020 Updated Nov. 30, 2020. Share full article. Image.

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...